Nepenthe, operating under the slogan "Araştırma Teknolojileri", was established in 2018 in Turkey. The company operates within the Biotechnology and Life Sciences industries, focusing specifically on research and development, as well as manufacturing of antibodies and related products.
The company is structured as an SME and is recognized for its highly motivated and dedicated team. With a clear vision to become one of the leaders in antibody manufacturing, Nepenthe prioritizes high-quality products and superior after-sales service to ensure customer satisfaction.
As of the latest available data, Nepenthe has not yet secured external investment, presenting a valuable opportunity for investors to engage with a promising company in a growing industry. The commitment to quality and innovation indicates a strong potential for future growth and market presence.